Glenn G. Coleman's Insider Trades & SAST Disclosures
Glenn G. Coleman's most recent trade in Premier Inc - Ordinary Shares - Class A was a trade of 143,475 Class A Common Stock done . Disclosure was reported to the exchange on Nov. 11, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Glenn G. Coleman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Premier Inc - Ordinary Sha... | Glenn G. Coleman | CAO & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2024 | 143,475 | 143,475 (0%) | 0% | 0 | Class A Common Stock | |
| DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2024 | 375 | 89,767 (0%) | 0% | 0 | Common Stock | |
| DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2024 | 12 | 1,892 | - | - | Phantom Stock (Supplemental Executive Retirement Plan) SERP | |
| DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2024 | 404 | 89,392 (0%) | 0% | 0 | Common Stock | |
| DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2024 | 11 | 1,879 | - | - | Phantom Stock (Supplemental Executive Retirement Plan) SERP | |
| DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2024 | 302 | 88,751 (0%) | 0% | 0 | Common Stock | |
| DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2024 | 9 | 1,868 | - | - | Phantom Stock (Supplemental Executive Retirement Plan) SERP | |
| DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 1,858 | 1,858 | - | - | Phantom Stock (Supplemental Executive Retirement Plan) SERP | |
| DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 62,800 | 62,800 | - | - | Stock Option (Right to Buy) | |
| DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 18,780 | 88,449 (0%) | 0% | 0 | Common Stock | |
| DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.27 per share. | 01 Mar 2024 | 1,683 | 69,669 (0%) | 0% | 33.3 | 55,993 | Common Stock |
| DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 193 | 71,352 (0%) | 0% | 0 | Common Stock | |
| DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.36 per share. | 22 Nov 2023 | 2,461 | 71,105 (0%) | 0% | 31.4 | 77,177 | Common Stock |
| DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Purchase of securities on an exchange or from another person at price $ 29.70 per share. | 20 Nov 2023 | 10,000 | 73,566 (0%) | 0% | 29.7 | 297,000 | Common Stock |
| DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.32 per share. | 15 Nov 2023 | 2,385 | 63,566 (0%) | 0% | 29.3 | 69,928 | Common Stock |
| DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2023 | 268 | 65,951 (0%) | 0% | 0 | Common Stock | |
| DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 228 | 65,683 (0%) | 0% | 0 | Common Stock | |
| DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2023 | 231 | 65,369 (0%) | 0% | 0 | Common Stock | |
| DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 49,700 | 49,700 | - | - | Stock Option (Right to Buy) | |
| DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 16,133 | 65,137 (0%) | 0% | 0 | Common Stock | |
| DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2023 | 378 | 49,004 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.00 per share. | 01 Jul 2022 | 6,666 | 34,622 (0%) | 0% | 55 | 366,630 | Common Stock |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Sale of securities on an exchange or to another person at price $ 66.04 per share. | 04 Apr 2022 | 6,268 | 41,288 (0%) | 0% | 66.0 | 413,939 | Common Stock |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 20,023 | 20,023 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 7,119 | 64,578 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 5,338 | 47,556 (0%) | 0% | 65.1 | 347,557 | Common Stock |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 3,706 | 59,765 (0%) | 0% | 65.1 | 241,298 | Common Stock |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 2,902 | 52,894 (0%) | 0% | 65.1 | 188,949 | Common Stock |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 1,770 | 57,995 (0%) | 0% | 65.1 | 115,245 | Common Stock |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 1,424 | 55 (0%) | 0% | 65.1 | 92,717 | Common Stock |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 1,107 | 63,471 (0%) | 0% | 65.1 | 72,077 | Common Stock |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 775 | 57,220 (0%) | 0% | 65.1 | 50,460 | Common Stock |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 12,576 | 57,459 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 10,837 | 44,883 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 5,892 | 34,046 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Sale of securities on an exchange or to another person at price $ 74.00 per share. | 02 Nov 2021 | 4,275 | 27,781 (0%) | 0% | 74 | 316,350 | Common Stock |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.41 per share. | 16 Apr 2021 | 25,658 | 57,714 (0%) | 0% | 19.4 | 498,022 | Common Stock |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2021 | 25,658 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Sale of securities on an exchange or to another person at price $ 71.50 per share. | 16 Apr 2021 | 25,658 | 32,056 (0%) | 0% | 71.5 | 1,834,547 | Common Stock |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Sale of securities on an exchange or to another person at price $ 70.50 per share. | 14 Apr 2021 | 4,002 | 32,056 (0%) | 0% | 70.5 | 282,141 | Common Stock |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Sale of securities on an exchange or to another person at price $ 70.00 per share. | 09 Apr 2021 | 12,500 | 36,058 (0%) | 0% | 70 | 875,000 | Common Stock |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2021 | 12,500 | 25,658 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.41 per share. | 09 Apr 2021 | 12,500 | 48,558 (0%) | 0% | 19.4 | 242,625 | Common Stock |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Sale of securities on an exchange or to another person at price $ 68.50 per share. | 29 Mar 2021 | 12,500 | 36,058 (0%) | 0% | 68.5 | 856,250 | Common Stock |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.41 per share. | 29 Mar 2021 | 12,500 | 48,558 (0%) | 0% | 19.4 | 242,625 | Common Stock |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2021 | 12,500 | 38,158 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Sale of securities on an exchange or to another person at price $ 68.50 per share. | 29 Mar 2021 | 3,000 | 36,058 (0%) | 0% | 68.5 | 205,500 | Common Stock |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 20,518 | 20,518 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 6,807 | 41,086 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 12 Mar 2021 | 990 | 40,096 (0%) | 0% | 68.1 | 67,419 | Common Stock |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 12 Mar 2021 | 523 | 39,573 (0%) | 0% | 68.1 | 35,616 | Common Stock |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 12 Mar 2021 | 515 | 39,058 (0%) | 0% | 68.1 | 35,072 | Common Stock |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Sale of securities on an exchange or to another person at price $ 56.03 per share. | 13 Nov 2020 | 2,600 | 33,894 (0%) | 0% | 56.0 | 145,666 | Common Stock |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Sale of securities on an exchange or to another person at price $ 54.34 per share. | 09 Nov 2020 | 4,907 | 40,987 (0%) | 0% | 54.3 | 266,668 | Common Stock |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Sale of securities on an exchange or to another person at price $ 56.04 per share. | 09 Nov 2020 | 4,400 | 36,494 (0%) | 0% | 56.0 | 246,597 | Common Stock |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Sale of securities on an exchange or to another person at price $ 55.04 per share. | 09 Nov 2020 | 93 | 40,894 (0%) | 0% | 55.0 | 5,119 | Common Stock |
| Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Sale of securities on an exchange or to another person at price $ 52.27 per share. | 11 Aug 2020 | 5,000 | 45,894 (0%) | 0% | 52.3 | 261,343 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges